Henlius Biotech’s Global Growth and Market Outlook

https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/76/8c/fd/768cfde9-8e57-0028-aa6a-ef17f02f4218/mza_9840273861972706894.jpg/600x600bb.jpg

The Smartkarma Podcast

Smartkarma

140 episodes

1 day ago

Weekly discussions with independent analysts and finance professionals from around the world, powered by Smartkarma's investment intelligence platform. Smartkarma empowers strategic decision-making through real-time actionable insight, premium data analytics, and direct connectivity to top-ranked investment analysts. Learn more at smartkarma.com.

Investing

Business

RSS

All content for The Smartkarma Podcast is the property of Smartkarma and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Investing

Business

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/8454895/8454895-1753173142415-d35e817fff049.jpg

Henlius Biotech’s Global Growth and Market Outlook

The Smartkarma Podcast

5 minutes 27 seconds

3 months ago

Henlius Biotech’s Global Growth and Market Outlook

Smart Calls with Smartkarma | Henlius Biotech (2696 HK): Profitability, Global Momentum, and Pipeline Strength

Henlius is among the few Chinese biopharma firms to turn profitable—with solid fundamentals, expanding global approvals (incl. EU & Southeast Asia), and an active late-stage pipeline.

Pranav Rao speaks with Criss Wang to explore the long-term upside potential (~20–50%), key risks like biosimilar VBP, and what investors should watch as sentiment drives sector rallies.

Like what you heard? Share this episode and follow us for more Smart Calls.

Read Criss’s full Insight - https://skr.ma/fUAck

Criss Wang - http://on.skr.ma/4lZWC5A

Henlius Biotech - http://on.skr.ma/3IUTCJo

This podcast is provided for general informational and entertainment purposes only, and is not intended to provide financial, investment or other professional advice. Views expressed by third parties do not necessarily represent Smartkarma’s views. Smartkarma assumes no responsibility or liability for the accuracy, compliance or completeness of the podcast or the information it contains. Users should not rely on the podcast or the information it contains when making individual, business or other strategic decisions and should always consult a qualified expert or professional adviser.